PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0DQ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $146,894
Award facts
- Contract value 100% obligated
- $146,893.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at approximately $146,900, was awarded on January 6, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., and is funded by the Defense Logistics Agency's Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. This delivery order operates under AmerSourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerSourceBergen's contract portfolio demonstrates significant capability in supplying a diverse array of pharmaceutical products and medical commodities to federal agencies, including specialty medications, brand-name and generic drugs, vaccines, medical devices, and therapeutic products spanning multiple medical domains. The company serves critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with anticipated multiple awards across separate regions, positioning AmerSourceBergen competitively within this strategic initiative to modernize federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2D826F0DQ1?
SPE2D826F0DQ1 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 6, 2026.
How much is contract SPE2D826F0DQ1 worth?
The government has obligated $146,894 on SPE2D826F0DQ1.
Is contract SPE2D826F0DQ1 an order under another contract?
Yes. SPE2D826F0DQ1 is a delivery order under SPE2DX22D0039, an indefinite delivery contract.
Was contract SPE2D826F0DQ1 competed?
The extent of competition for SPE2D826F0DQ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award